Summary: EPA, FDA, and USDA unveil two documents as part of the Administration’s continuing effort to modernize the Federal regulatory system for biotechnology products. Today, the Federal government has taken an important step to ensure public confidence in the regulatory system for biotechnology products and to improve the transparency, predictability, coordination, and, ultimately, efficiency of that system. In 1986, the White House Office of Science and Technology Policy (OSTP) issued the Coordinated Framework for the Regulation of Biotechnology, which outlined a comprehensive Federal regulatory policy for ensuring the safety of biotechnology products.
James Kim is a toxicologist in the Office of Information and Regulatory Affairs at the Office of Management and Budget.
- Health Tech Sprint Aims at Improving Care Access and Experience
- GSA Steps Up Security for .gov
- A Design Challenge to Improve How School Data is Reported
- Want a More Innovative Agency? Encourage Employees to Experiment
- Collaborating for Better Design, Technology, and User Experience